Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer
Authors
Keywords
-
Journal
Nutrients
Volume 11, Issue 4, Pages 898
Publisher
MDPI AG
Online
2019-04-22
DOI
10.3390/nu11040898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Morbidity associated with overweight and obesity in health personnel: a 10-year retrospective of hospital-based cohort study in Taiwan
- (2019) Tzu-Lin Yeh et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Targeting Glutamine Metabolism for Cancer Treatment
- (2018) Yeon-Kyung Choi et al. Biomolecules & Therapeutics
- Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile
- (2018) Fangyu Jing et al. IUBMB LIFE
- Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival
- (2018) Päivi Sirniö et al. BRITISH JOURNAL OF CANCER
- Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer
- (2018) Faisal Shahjehan et al. Frontiers in Oncology
- Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women
- (2017) Wenjie Ma et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study
- (2017) Paweł Dereziński et al. International Journal of Medical Sciences
- Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis
- (2017) Szymon Plewa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma
- (2017) Fan Zhang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer
- (2017) Jiaqiu Li et al. Oncotarget
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
- (2016) Farshad Farshidfar et al. BRITISH JOURNAL OF CANCER
- Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
- (2016) Yujun Hao et al. Nature Communications
- Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-αlevels predict the progression of colorectal cancer
- (2016) Pei-Hung Chang et al. Cancer Medicine
- Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams
- (2016) Candyce H. Kroenke et al. JAMA Oncology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Baseline dietary glutamic acid intake and the risk of colorectal cancer: The Rotterdam study
- (2015) Gilson G. Viana Veloso et al. CANCER
- A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites
- (2015) Yan Zhang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review
- (2015) Maryam Miraghajani et al. Journal of Research in Medical Sciences
- Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients
- (2015) Gaojie Liu et al. Journal of Translational Medicine
- Glutamine at focus: versatile roles in cancer
- (2015) Humberto De Vitto et al. TUMOR BIOLOGY
- Association between Body Mass Index and Prognosis of Colorectal Cancer: A Meta-Analysis of Prospective Cohort Studies
- (2015) Junga Lee et al. PLoS One
- Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling
- (2014) Jiangjiang Zhu et al. JOURNAL OF PROTEOME RESEARCH
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolomics in cancer biomarker discovery: Current trends and future perspectives
- (2013) Emily G. Armitage et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Metabonomics Identifies Serum Metabolite Markers of Colorectal Cancer
- (2013) Binbin Tan et al. JOURNAL OF PROTEOME RESEARCH
- Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer
- (2011) Atsuki Ikeda et al. BIOMEDICAL CHROMATOGRAPHY
- Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal Cancer
- (2011) I. Bertini et al. CANCER RESEARCH
- Cytokines, Inflammation and Colon Cancer
- (2011) L. Klampfer CURRENT CANCER DRUG TARGETS
- Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy - a randomized crossover study
- (2009) Y. LI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
- (2009) R J DeBerardinis et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now